Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.
暂无分享,去创建一个
K. Feder | B. Saloner | Brendan Saloner | Kenneth A Feder | Noa Krawczyk | Caroline E Picher | N. Krawczyk
[1] L. Møller,et al. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. , 2012, Addiction.
[2] S. Prins. Prevalence of mental illnesses in US State prisons: a systematic review. , 2014, Psychiatric services.
[3] D. Marlowe,et al. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. , 2012, Journal of substance abuse treatment.
[4] M. Farrell,et al. Meta-analysis of drug-related deaths soon after release from prison , 2010, Addiction.
[5] S. Sigmon. Access to treatment for opioid dependence in rural America: challenges and future directions. , 2014, JAMA psychiatry.
[6] C. Barry,et al. Justice-Involved Adults With Substance Use Disorders: Coverage Increased But Rates Of Treatment Did Not In 2014. , 2016, Health affairs.
[7] P. Hora. Trading One Drug for Another? What Drug Treatment Court Professionals Need to Learn About Opioid Replacement Therapy , 2005 .
[8] H. W. Clark,et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. , 2000, JAMA.
[9] C. Cunningham,et al. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder , 2015, Addiction Science & Clinical Practice.
[10] H. Connery. Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions , 2015, Harvard review of psychiatry.
[11] P. Friedmann,et al. Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions , 2012, Substance abuse.
[12] Thomas R Frieden,et al. Medication-assisted therapies--tackling the opioid-overdose epidemic. , 2014, The New England journal of medicine.
[13] M. Anglin,et al. Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36. , 2013, American journal of public health.
[14] J. Sorensen,et al. Access to Care for Methadone Maintenance Patients in the United States , 2009, International Journal of Mental Health and Addiction.
[15] D. Festinger,et al. Attitudes and practices on the use of extended-release naltrexone in criminal justice settings , 2017 .
[16] Patrick Royston,et al. Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.
[17] K. O’grady,et al. Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment. , 2017, Contemporary clinical trials.
[18] J. Hahn,et al. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. , 2014, JAMA internal medicine.
[19] B. Fischer,et al. Impact of Methadone Maintenance Treatment on Women Offenders' Post-Release Recidivism , 2014, European Addiction Research.
[20] Alex Harocopos,et al. Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma. , 2016, Journal of substance abuse treatment.
[21] K. Kampman,et al. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use , 2015, Journal of addiction medicine.
[22] Douglas B. Marlowe,et al. Integrating Substance Abuse Treatment and Criminal Justice Supervision , 2003, Science & practice perspectives.
[23] Alex H. S. Harris,et al. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. , 2016, Drug and alcohol dependence.
[24] Alex H. S. Harris,et al. Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness , 2016, Addiction Science & Clinical Practice.
[25] J. Elmore,et al. Release from prison--a high risk of death for former inmates. , 2007, The New England journal of medicine.
[26] L. Degenhardt,et al. Mitigating the risk of HIV infection with opioid substitution treatment. , 2013, Bulletin of the World Health Organization.
[27] K. Sabin,et al. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention , 2005, AIDS.
[28] J. Savolainen,et al. Participation in opioid substitution treatment reduces the rate of criminal convictions: evidence from a community study. , 2013, Addictive behaviors.
[29] L. Degenhardt,et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies , 2017, British Medical Journal.
[30] W. Ling,et al. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). , 2013, Journal of studies on alcohol and drugs.
[31] J. Rich,et al. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. , 2009, Drug and alcohol dependence.
[32] K. Feder,et al. Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. , 2017, Drug and alcohol dependence.
[33] C. B. Clark,et al. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision. , 2014, Addictive behaviors.
[34] Lori J. Ducharme,et al. Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. , 2015, Journal of substance abuse treatment.
[35] J. Laurent,et al. Screaming Behind a Door , 2016, Journal of correctional health care : the official journal of the National Commission on Correctional Health Care.